Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetic biclonality in malignant hematologic disorders.

T Furuya1, R Morgan, A A Sandberg

  • 1Cancer Center of Southwest Biomedical Research Institute, Scottsdale, AZ 85251.

Cancer Genetics and Cytogenetics
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992
Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010
Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010
Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010
Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010
Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010
Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010
See all related articles

Malignant hematologic disorders are often monoclonal. However, this study found evidence of cytogenetically unrelated clones, suggesting hematopoietic biclonality in conditions like acute leukemia and myelodysplastic syndromes.

Area of Science:

  • Hematology
  • Cancer Genetics
  • Cytogenetics

Background:

  • Malignant hematologic disorders are typically considered monoclonal in origin.
  • Previous reports have documented cytogenetically unrelated clones in specific hematologic malignancies, but these are rare.

Purpose of the Study:

  • To investigate the occurrence and implications of cytogenetically unrelated clones in malignant hematologic disorders.
  • To determine if the presence of multiple unrelated clones suggests a broader phenomenon of hematopoietic biclonality.

Main Methods:

  • Review of case studies and literature data on patients with malignant hematologic disorders.
  • Karyotypic analysis to identify distinct cytogenetic abnormalities and clonal populations.
  • Correlation of cytogenetic findings with specific hematologic diagnoses.

Related Experiment Videos

Main Results:

  • The study identified cases of acute leukemia (AL), acute lymphoblastic leukemia (ALL), acute myeloblastic leukemia (AMMoL), and myelodysplastic syndromes (MDS) with cytogenetically unrelated clones.
  • Trisomy 8 was the most frequent abnormality (75%), followed by trisomy 21 (37.5%) and trisomy 11 (25%).
  • Specific combinations, such as trisomy 8 and deletion of chromosome 5 long arm (5q-), were observed in both MDS and acute leukemia, including acute nonlymphocytic leukemia (ANNL) and chronic myelogenous leukemia (CML) in blastic crisis.

Conclusions:

  • The presence of cytogenetically unrelated clones in malignant hematologic disorders challenges the traditional monoclonal origin theory.
  • Findings suggest that hematopoietic biclonality, indicated by multiple unrelated clones, may be a more common phenomenon than previously recognized.
  • Further research is warranted to understand the mechanisms and clinical significance of hematopoietic biclonality.